December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Korro Bio, Inc. - Common Stock (NQ:KRRO)

10.74 -0.20 (-1.83%)
Streaming Delayed Price Updated: 2:32 PM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Korro Bio, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗
This strategic play will take time to pay off, but it could keep growth going. 
Via The Motley Fool
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications ↗
Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (NYSE:NVO) to advance the ... 
Via Benzinga
News headline image
Gold Edges Lower; US Homebuilder Sentiment Rises For September ↗
 
Via Benzinga
News headline image
Crude Oil Gains Over 1%; US Business Inventories Increase In July ↗
 
Via Benzinga
News headline image
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating ↗
William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1... 
Via Benzinga
News headline image
KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024 ↗
KRRO stock results show that Korro Bio missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023 ↗
KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024 ↗
KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Why Newly Listed Korro Bio Shares Are Gaining Today ↗
H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat various diseases. 
Via Benzinga
News headline image
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024? ↗
These stocks are coming off a banner month, but what about the road ahead? 
Via The Motley Fool
News headline image
Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.